Nested Applications



EFORT invites you to browse through the Exhibitors Database of the 25th EFORT Annual Congress Hamburg 2024 which represents those exhibitors that have already committed to and confirmed their presence at the EFORT Congress to be held in Hamburg, Germany from 22 to 24 May 2024. 

Should you wish to exhibit, please check the online EFORT WEBSHOP.

EFORT Industry Database


V Areálu 1243
252 42 Jesenice
Czech Republic
Phone: +420 241 432 133
About Us

InProfex was founded with the goal of introducing highly innovative pharmaceuticals, medical devices, and dietary supplements to the European markets. One result of such innovation is the collagen injection CHondroGrid for the treatment of osteoarthritis of the musculoskeletal system and Vitamin C with liposomal absorption, Lipo C Askor Forte.

InProfex GmbH is part of a group led by the company inPharm, which has been present for 30 years as a European pharmaceutical distribution company with a central warehouse for Europe located in the strategically important city of Prague. The group also includes the immunological inPharm Clinic (www.inpharmclinic.cz), whose infusion protocol for administering biogenic drugs is based particularly on collaboration with American university hospitals in Kansas and Iowa. The mentioned therapy protocol represents a gentle and innovative treatment aimed at supporting the immune system and other systems by, among other things, being used in the prevention and treatment of autoimmune diseases, oncological conditions, and other diseases.

Two Pinnacles of Innovation

The dietary supplement Lipo C Askor Forte represents the latest pinnacle of innovation as it involves Vitamin C with liposomal absorption and Uro C Control test strips, which are capable of providing information about the capacity of Vitamin C in the organism. This can be considered a huge gain for medicine and pharmacy, as now every individual is able to adequately adjust the Vitamin C levels in their organism, thus ensuring the necessary antioxidative protection for healthy cells and the proper function of the immune, nervous, musculoskeletal, and cardiovascular systems, which are systems whose correct daily activity is physiologically and existentially dependent on Vitamin C. Otherwise, we would continue to rely on the daily dosage recommendations published in the literature, which would not be correct in the case of Vitamin C, as its daily consumption is defined by the day-to-day physical and mental demands.

Furthermore, the collagen injection mentioned above can also be considered a pinnacle of innovation. Osteoarthritis is the most common joint disease of the musculoskeletal system. Treatment options are limited, and the most commonly used drugs, such as oral nonsteroidal anti-inflammatory drugs or intra-articularly administered corticosteroids, are associated with significant unwanted side effects. According to the latest meta-analyses, hyaluronic acid (HA), platelet-rich plasma (PRP), or stem cells (MSC) also do not provide long-term relief from joint pain. This situation leads to a search for new treatment modalities. Indeed, one of the new possibilities is the application of hydrolyzed collagen by injection, including for the treatment of gonarthrosis (osteoarthritis of the knee), which leads to significant clinical improvement without unwanted effects. As the results of current studies have shown, the injection of hydrolyzed collagen affects the chondrocytes of the cartilage-rich tissue of the osteoarthritic joint cartilage, where these cells formed a stronger extracellular matrix and produced more type II collagen, characteristic of joint cartilage, compared to controls.

Today, InProfex GmbH belongs to the extremely dynamically growing, interesting, and reputable companies, which rely on the thorough study of medical physiology, molecular biology, immunology, and the issues of appropriate and rational pharmacotherapy. The main goal is to strengthen the body's defenses against those risk factors which impair health or homeostasis, which is of fundamental importance for the prevention and treatment of diseases. Due to its innovative thinking, the inPharm Clinic, and the capabilities of its management, the company is very successful in improving the quality of life of all segments of the population.

More information:

- https://inprofex.at/

- https://chondrogrid.de/

Area of Business: Pharmaceutical Manufacturing
Category: Pharmaceutical Manufacturing
Number of Employees worldwide: 11-50 employees
Founded in: 1993
No products found.

Nested Applications

HAM24 WebShop banner

Nested Applications



Feel free to use these templates to announce your presence as an exhibitor at the EFORT Congress.
Find two versions available for your social media (Instagram/Facebook and Twitter/LinkedIn formats) .



Find more resources at the
EFORT Congress Resource Center


HAM24 Compliance Blurb

Ethical MedTech Compliance

EFORT is recognised as "Compliant" on the Ethical MedTech Platform for its 25th EFORT Congress taking place in Hamburg, Germany, from the 22 to the 24 May 2024. Thanks to all our corporate partners already attending - we look forward to seeing you there!

HAM24 Scientific Programme banner Square

EFORT Annual Congress: Past Exhibitors

Past EFORT Congresses Exhibitors

EFORT understands that in order to assess the relevance of your company exhibiting during our EFORT Congresses – it is often useful to see which companies have exhibited at previous EFORT congresses. For your convenience, therefore, please find the complete exhibitor listings for the following annual congresses via the links below:

For any inquiries relating to exhibition, satellites and sponsorship – please contact by using the official exhibitors and sponsorship contact us online form.

Note*: The global Covid-19 pandemic forced EFORT to take the difficult decision to postpone the 21st and 22nd EFORT Annual Congresses that was formerly planned to be held in Vienna, Austria in June 2020 and June-July 2021 respectively.